Istoplasmosi

Una malattia non solo tropicale

Translated title of the contribution: Histoplasmosis, not only a tropical disease

Enrico Rino Bregani, Tu Van Tien, Tiziana Ceraldi, Cristina Delfitto, Giovanni Figini

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Histoplasmosis is a fungal infection resulting from inhalation of spores from the fungus Histoplasma capsulatum; it is known to be endemic in various parts of the world, especially in North and Latin America, and can produce a spectrum of illness, from subclinical infection to progressive disseminated disease. The majority of infected persons have an asymptomatic, self-limiting illness. Clinical pneumonia occurs in those with exposure to a large number of infecting spores. Disseminated histoplasmosis usually occurs in immunosuppressed patients or in patients with chronic illness. Diagnosis is best made by visualization of yeast in tissue or by culture. In most cases, amphotericin B is the initial drug of choice, followed by one of the azoles for lifelong maintenance therapy. Itraconazole is the drug of choice for treatment of disseminated histoplasmosis in less severe cases, while fluconazole therapy for histoplasmosis is only moderately effective.

Original languageItalian
Pages (from-to)396-401
Number of pages6
JournalRecenti Progressi in Medicina
Volume91
Issue number7-8
Publication statusPublished - Jul 2000

Fingerprint

Histoplasmosis
Spores
Histoplasma
Azoles
Asymptomatic Infections
Itraconazole
Latin America
Mycoses
Fluconazole
Amphotericin B
North America
Pharmaceutical Preparations
Inhalation
Pneumonia
Chronic Disease
Fungi
Therapeutics
Yeasts

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bregani, E. R., Van Tien, T., Ceraldi, T., Delfitto, C., & Figini, G. (2000). Istoplasmosi: Una malattia non solo tropicale. Recenti Progressi in Medicina, 91(7-8), 396-401.

Istoplasmosi : Una malattia non solo tropicale. / Bregani, Enrico Rino; Van Tien, Tu; Ceraldi, Tiziana; Delfitto, Cristina; Figini, Giovanni.

In: Recenti Progressi in Medicina, Vol. 91, No. 7-8, 07.2000, p. 396-401.

Research output: Contribution to journalArticle

Bregani, ER, Van Tien, T, Ceraldi, T, Delfitto, C & Figini, G 2000, 'Istoplasmosi: Una malattia non solo tropicale', Recenti Progressi in Medicina, vol. 91, no. 7-8, pp. 396-401.
Bregani ER, Van Tien T, Ceraldi T, Delfitto C, Figini G. Istoplasmosi: Una malattia non solo tropicale. Recenti Progressi in Medicina. 2000 Jul;91(7-8):396-401.
Bregani, Enrico Rino ; Van Tien, Tu ; Ceraldi, Tiziana ; Delfitto, Cristina ; Figini, Giovanni. / Istoplasmosi : Una malattia non solo tropicale. In: Recenti Progressi in Medicina. 2000 ; Vol. 91, No. 7-8. pp. 396-401.
@article{7c409143af844ab19883ab44fd3c5551,
title = "Istoplasmosi: Una malattia non solo tropicale",
abstract = "Histoplasmosis is a fungal infection resulting from inhalation of spores from the fungus Histoplasma capsulatum; it is known to be endemic in various parts of the world, especially in North and Latin America, and can produce a spectrum of illness, from subclinical infection to progressive disseminated disease. The majority of infected persons have an asymptomatic, self-limiting illness. Clinical pneumonia occurs in those with exposure to a large number of infecting spores. Disseminated histoplasmosis usually occurs in immunosuppressed patients or in patients with chronic illness. Diagnosis is best made by visualization of yeast in tissue or by culture. In most cases, amphotericin B is the initial drug of choice, followed by one of the azoles for lifelong maintenance therapy. Itraconazole is the drug of choice for treatment of disseminated histoplasmosis in less severe cases, while fluconazole therapy for histoplasmosis is only moderately effective.",
keywords = "AIDS, Antifungal therapy, Histoplasmosis, Opportunistic infection",
author = "Bregani, {Enrico Rino} and {Van Tien}, Tu and Tiziana Ceraldi and Cristina Delfitto and Giovanni Figini",
year = "2000",
month = "7",
language = "Italian",
volume = "91",
pages = "396--401",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "7-8",

}

TY - JOUR

T1 - Istoplasmosi

T2 - Una malattia non solo tropicale

AU - Bregani, Enrico Rino

AU - Van Tien, Tu

AU - Ceraldi, Tiziana

AU - Delfitto, Cristina

AU - Figini, Giovanni

PY - 2000/7

Y1 - 2000/7

N2 - Histoplasmosis is a fungal infection resulting from inhalation of spores from the fungus Histoplasma capsulatum; it is known to be endemic in various parts of the world, especially in North and Latin America, and can produce a spectrum of illness, from subclinical infection to progressive disseminated disease. The majority of infected persons have an asymptomatic, self-limiting illness. Clinical pneumonia occurs in those with exposure to a large number of infecting spores. Disseminated histoplasmosis usually occurs in immunosuppressed patients or in patients with chronic illness. Diagnosis is best made by visualization of yeast in tissue or by culture. In most cases, amphotericin B is the initial drug of choice, followed by one of the azoles for lifelong maintenance therapy. Itraconazole is the drug of choice for treatment of disseminated histoplasmosis in less severe cases, while fluconazole therapy for histoplasmosis is only moderately effective.

AB - Histoplasmosis is a fungal infection resulting from inhalation of spores from the fungus Histoplasma capsulatum; it is known to be endemic in various parts of the world, especially in North and Latin America, and can produce a spectrum of illness, from subclinical infection to progressive disseminated disease. The majority of infected persons have an asymptomatic, self-limiting illness. Clinical pneumonia occurs in those with exposure to a large number of infecting spores. Disseminated histoplasmosis usually occurs in immunosuppressed patients or in patients with chronic illness. Diagnosis is best made by visualization of yeast in tissue or by culture. In most cases, amphotericin B is the initial drug of choice, followed by one of the azoles for lifelong maintenance therapy. Itraconazole is the drug of choice for treatment of disseminated histoplasmosis in less severe cases, while fluconazole therapy for histoplasmosis is only moderately effective.

KW - AIDS

KW - Antifungal therapy

KW - Histoplasmosis

KW - Opportunistic infection

UR - http://www.scopus.com/inward/record.url?scp=0033834742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033834742&partnerID=8YFLogxK

M3 - Articolo

VL - 91

SP - 396

EP - 401

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 7-8

ER -